SARS-CoV-2 infection prevalence and associated factors: a serial population-based study in Espírito Santo, Brazil, May to June 2020.

Objective: To analyze SARS-CoV-2 seroprevalence and association of sociodemographic and clinical aspects in the state of Espírito Santo, Brazil.

Methods: This was a serial cross-sectional study carried out in four phases, using households as the unit of analysis, from May to June 2020. Eleven municipalities were surveyed, with a sample of 4,500 households in each phase.

Serological prevalence of SARS-CoV-2 infection among prison system workers in the state of Espírito Santo, Brazil, 2020.

Objective: To estimate the serological prevalence of SARS-CoV-2 infection among prison system workers in the state of Espírito Santo, Brazil, between August-September 2020.

Methods: This was a stratified sample survey, using interviews and serological tests for SARS-CoV-2.

Results: Among the 986 interviewers, the serological prevalence of SARS-CoV-2 infection was 11.

Living conditions, seroprevalence and symptoms of COVID-19 in slums in the Metropolitan Region of Vitória (Espírito Santo).

Objectives: to estimate the prevalence of SARS-CoV-2 infection in residents of the Greater Vitória region living in subnormal and non-subnormal agglomerates, and to compare sociodemographic and clinical characteristics of total residents (infected and not infected with SARS-CoV-2) between them.

Methods: Population-based prevalence study conducted by serological testing in 2020, with a study unit in households in Greater Vitória, grouped into census tracts classified as sub-normal agglomerates and non-sub-normal agglomerates. The two groups were compared in terms of prevalence and associated factors.

Vulnerable populations and tuberculosis treatment outcomes in Brazil.

This article aims to assess the association between being a prisoner or homeless and treatment failure in cases of tuberculosis diagnosed in Brazil in 2015. We examined cases of tuberculosis in prisoners and the homeless in Brazil in 2015 reported to the national notifiable diseases information system using descriptive analysis and logistic regression. There were 82,056 cases of tuberculosis in 2015.

Backdrop to the development of Brazil's national COVID-19 immunization plan.

The process of developing Brazil's COVID-19 immunization plan began belatedly and involved a number of experts, including a technical group responsible for defining priority groups for vaccination. This process was permeated by contradictions between the government and researchers. Finally, on 20 January 2021, the government published an updated version of the plan, which remains limited in scope.

Factors associated with tuberculosis in persons deprived of liberty in Espírito Santo.

OBJECTIVES To calculate the rate of tuberculosis cases per prison unit in Espírito Santo; present the individual, clinical, and institutional characteristics of the cases in persons deprived of liberty (PPL); and analyze the association between these characteristics and treatment outcome in this population. METHODS The study included cases of tuberculosis in the PPL of Espírito Santo from 2014 to 2016. Rate calculation, descriptive analysis and hierarchical logistic regression were performed considering the individual, clinical and institutional levels.

Tuberculosis in the Brazilian imprisoned population, 2007-2013.

Objective: to describe socio-demographic and clinical characteristics and indicators of tuberculosis (TB) in Brazilian imprisoned population, from 2007 to 2013.

Methods: descriptive study with data from the Information System for Notifiable Diseases (Sinan).

Results: from 2007 to 2013, 38,083 TB cases were reported in the imprisoned population, equivalent to a TB prevalence of 1,236 cases/100,000 individuals; this prevalence was higher among women (1,693/100,000), indigenous people (2,874/100,000), and in the age group >60 years (4,093/100,000); there were mainly reports of cases of pulmonary TB (91.

[Predictors of changes in drug regimens for treating AIDS in children].

To identify the causes of changes in therapeutic regimens for treating AIDS in children infected through vertical transmission. This was a case-control study in which the control group consisted of 49 children who had not had any changes to their antiretroviral regimen and the case group consisted of 62 children who had had changes between January 2000 and December 2005. Data from the patients' medical files and a semistructured interview were used.